The ANKRD30A Polyclonal Antibody (PACO00394) is a valuable tool for researchers studying ANKRD30A, a protein involved in various cellular processes such as cell signaling and gene regulation. This antibody, generated in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blot applications. By binding specifically to the ANKRD30A protein, this antibody facilitates the detection and analysis of ANKRD30A in different cell types, making it ideal for studies in molecular biology and cell biology.
ANKRD30A, also known as ankyrin repeat domain-containing protein 30A, plays a crucial role in regulating cellular functions such as gene expression and protein-protein interactions. Its involvement in these processes makes it a promising target for research in fields such as cancer biology, developmental biology, and neurobiology. Understanding the role of ANKRD30A may provide insights into disease mechanisms and potential therapeutic strategies targeting this protein.
Antibody Name:
ANKRD30A Antibody
Antibody SKU:
PACO00394
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB, IHC
Recommended Dilutions:
WB:1:500-1:2000, IHC:1:100-1:300
Species Reactivity:
Human
Immunogen:
synthesized peptide derived from the C-terminal region of human ANKRD30A.
Form:
Liquid
Storage Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Synonyms:
ANKRD30A; Ankyrin repeat domain-containing protein 30A; Serologically defined breast cancer antigen NY-BR-1
UniProt Protein Function:
CautionIt is uncertain whether Met-1 or Met-57 is the initiator.
NCBI Summary:
This gene encodes a DNA-binding transcription factor that is uniquely expressed in mammary epithelium and the testis. Altered expression levels have been associated with breast cancer progression. [provided by RefSeq, Nov 2016]
